Skip to main content
64°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Revelation Biosciences, Inc. - Common Stock
(NQ:
REVB
)
0.8594
+0.0444 (+5.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revelation Biosciences, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Why Cardiovascular Systems Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
February 09, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 09, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 09, 2023
We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday!
Via
InvestorPlace
Revelation Biosciences Outlines Plans Human Trial For Lead Fibrosis Candidate
November 18, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 08, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 08, 2023
On Wednesday, 20 companies achieved new lows for the year.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 07, 2023
Via
Benzinga
Revelation Biosciences Reveals Encouraging Preclinical Data From Its Lead Fibrosis Candidate
February 07, 2023
Via
Benzinga
Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300
February 07, 2023
From
Revelation Biosciences Inc.
Via
Business Wire
Revelation Biosciences Inc. Announces 1-for-35 Reverse Stock Split effective February 1, 2023 and Results of Special Meeting of Stockholders
January 31, 2023
From
Revelation Biosciences Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 24, 2023
Via
Benzinga
Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket
January 24, 2023
Gainers Axcella Health Inc. (NASDAQ: AXLA) rose 71.7% to $0.7450 in pre-market trading after the company reported regulatory path to registration of AXA1125 for long COVID-19 fatigue.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 17, 2023
Via
Benzinga
Revelation Biosciences Inc. Announces Mandatory Unit Separation to Occur on January 13, 2023
January 10, 2023
From
Revelation Biosciences Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 10, 2023
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Tuesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
January 06, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 13, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday morning!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 02, 2022
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Friday morning!
Via
InvestorPlace
Earnings Scheduled For November 21, 2022
November 21, 2022
Companies Reporting Before The Bell • Zepp Health (NYSE:ZEPP) is expected to report quarterly earnings at $0.54 per share on revenue of $186.58 million.
Via
Benzinga
Revelation Biosciences Inc. Announces Future Clinical Development Plans Based on Recent Biomarker Analysis and Significant Reduction in New Collagen Deposition (Fibrosis) in Preclinical Model
November 18, 2022
From
Revelation Biosciences Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 15, 2022
Via
Benzinga
Revelation Biosciences Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2022 and Recent Corporate Progress
November 10, 2022
From
Revelation Biosciences Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
November 10, 2022
During Thursday's session, 97 companies made new 52-week lows.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
November 04, 2022
We're starting off the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 03, 2022
We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 01, 2022
Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!
Via
InvestorPlace
Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
October 27, 2022
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 26, 2022
Gainers
Via
Benzinga
Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session
October 26, 2022
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 26, 2022
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 47.9% to $0.31 during Wednesday's pre-market session. The company's market cap stands at $11.8 million.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.